Terrence R Sullivan, MD
Urology · Los Gatos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sullivan’s office at (408) 590-3159 to ask if they take your plan before you enroll.
California Medical Board record
Licence G25099 · Current
Licensed to practise in California · since 1973 · expires 2029-02-28 · Saint Louis University School of Medicine.
Public record actions
| 2006-09-28 | Board disciplineDiscipline | Probation completed. · 03 1997081928 |
Surgery centers they own
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
Original Medicare doctor bills
$2,353
Medicare paid this office $2,353 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,493 | $115 |
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 80 · Under 65 0% · Health risk score 2.16. Sicker patients than 9 in 10 peers; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75%.
The office billed $5,975, Medicare allowed $2,953 and paid $2,353; for 20 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 20 | 80 | 2.16 | $5,975 | $2,353 |
| 2022 | 171 | 18,074 | 77 | 1.27 | $121,294 | $38,453 |
| 2021 | 234 | 48,315 | 77 | 1.40 | $212,309 | $68,796 |
| 2020 | 259 | 61,015 | 77 | 1.42 | $246,289 | $69,452 |
| 2019 | 329 | 66,225 | 77 | 1.42 | $317,155 | $98,164 |
| 2018 | 362 | 54,399 | 77 | 1.41 | $311,487 | $96,767 |
| 2017 | 364 | 38,323 | 77 | 1.38 | $296,825 | $96,034 |
| 2016 | 403 | 39,044 | 77 | 1.46 | $362,476 | $118,285 |
| 2015 | 442 | 53,702 | 77 | 1.37 | $438,982 | $150,738 |
| 2014 | 426 | 4,137 | 77 | 1.29 | $371,631 | $125,824 |
| 2013 | 503 | 1,901 | 77 | 1.28 | $436,219 | $144,263 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 3 services
| Short return visit (20+ min) | 152 | $16,061 | $72 |
| Return visit (30+ min) | 15 | $2,040 | $113 |
| Manual urinalysis test with examination using microscope, automated | 140 | $610 | $3 |
2021: 11 services
| Short return visit (20+ min) | 192 | $28,753 | $78 |
| Short return visit | 13 | $7,437 | $53 |
| Return visit (30+ min) | 27 | $3,234 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,613 | $119 |
| Injection of drug or substance under skin or into muscle | 14 | $2,185 | $14 |
| Simple bladder irrigation and/or instillation | 14 | $1,717 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,451 | $66 |
| New patient visit (30+ min) | 14 | $1,422 | $102 |
| Injection, testosterone cypionate, 1 mg | 14 | $1,075 | None |
| Manual urinalysis test with examination using microscope, automated | 172 | $897 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 22 | $250 | $10 |
2020: 9 services
| Short return visit (20+ min) | 217 | $23,560 | $62 |
| Short return visit | 15 | $7,841 | $42 |
| Injection of drug or substance under skin or into muscle | 13 | $2,610 | $13 |
| Return visit (30+ min) | 16 | $2,529 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,514 | $126 |
| New patient visit (30+ min) | 17 | $1,653 | $97 |
| Injection, testosterone cypionate, 1 mg | 13 | $1,289 | None |
| Manual urinalysis test with examination using microscope, automated | 182 | $866 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 25 | $300 | $9 |
2019: 15 services
| Short return visit (20+ min) | 271 | $35,190 | $62 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $15,013 | None |
| Short return visit | 15 | $8,075 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $4,053 | $123 |
| Return visit (30+ min) | 29 | $3,522 | $98 |
| Injection of drug or substance under skin or into muscle | 14 | $3,420 | $16 |
| New patient visit (30+ min) | 36 | $3,038 | $84 |
| Ultrasound measurement of bladder capacity after voiding | 111 | $2,215 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,162 | $66 |
| Simple bladder irrigation and/or instillation | 11 | $1,583 | $75 |
| Manual urinalysis test with examination using microscope, automated | 248 | $1,580 | $3 |
| Complete ultrasound scan behind abdominal cavity | 12 | $1,385 | $115 |
| Injection, testosterone cypionate, 1 mg | 14 | $1,313 | None |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $870 | $29 |
| Manual urinalysis test with examination using microscope, non-automated | 30 | $122 | $4 |
2018: 14 services
| Short return visit (20+ min) | 284 | $34,524 | $61 |
| Short return visit | 17 | $6,525 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $4,576 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,562 | $120 |
| New patient visit (30+ min) | 52 | $4,501 | $87 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $3,562 | $148 |
| Injection of drug or substance under skin or into muscle | 16 | $3,536 | $20 |
| Manual urinalysis test with examination using microscope, non-automated | 268 | $1,816 | $4 |
| Return visit (30+ min) | 15 | $1,366 | $91 |
| Ultrasound measurement of bladder capacity after voiding | 58 | $1,297 | $15 |
| Complete ultrasound scan behind abdominal cavity | 11 | $1,206 | $110 |
| Injection, testosterone cypionate, 1 mg | 15 | $975 | None |
| Simple bladder irrigation and/or instillation | 13 | $897 | $64 |
| Manual urinalysis test with examination using microscope, automated | 15 | $58 | $4 |
2017: 13 services
| Short return visit (20+ min) | 262 | $28,396 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 11 | $12,089 | None |
| New patient visit (30+ min) | 61 | $5,591 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $5,248 | $119 |
| Short return visit | 16 | $4,798 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,599 | $65 |
| Return visit (30+ min) | 31 | $3,896 | $93 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $3,669 | $153 |
| Injection of drug or substance under skin or into muscle | 13 | $3,077 | $24 |
| Simple bladder irrigation and/or instillation | 17 | $1,991 | $71 |
| Manual urinalysis test with examination using microscope, non-automated | 276 | $1,880 | $4 |
| Ultrasound measurement of bladder capacity after voiding | 32 | $794 | $19 |
| Injection, testosterone cypionate, 1 mg | 11 | $642 | None |
2016: 16 services
| Short return visit (20+ min) | 305 | $32,452 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 16 | $20,043 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $7,003 | $115 |
| Short return visit | 33 | $5,335 | $37 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $5,321 | $172 |
| New patient visit (30+ min) | 58 | $5,228 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,520 | $62 |
| Return visit (30+ min) | 28 | $2,918 | $88 |
| Biopsy of prostate gland | 13 | $2,442 | $188 |
| Injection of drug or substance under skin or into muscle | 13 | $2,384 | $24 |
| Manual urinalysis test with examination using microscope, non-automated | 304 | $2,141 | $4 |
| Simple bladder irrigation and/or instillation | 21 | $2,019 | $72 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $1,342 | $30 |
| Injection, testosterone cypionate, 1 mg | 14 | $765 | None |
| Ultrasonic guidance for needle placement | 13 | $678 | $52 |
| Ultrasound measurement of bladder capacity after voiding | 26 | $502 | $17 |
2015: 21 services
| Short return visit (20+ min) | 277 | $29,506 | $62 |
| Return visit (30+ min) | 161 | $19,567 | $91 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $17,708 | None |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $6,799 | $486 |
| New patient visit (45+ min) | 46 | $6,639 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,082 | $179 |
| Short return visit | 26 | $5,866 | $37 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $5,361 | $185 |
| Biopsy of prostate gland | 17 | $3,492 | $205 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $2,338 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,115 | $64 |
| Simple bladder irrigation and/or instillation | 22 | $2,000 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,937 | $121 |
| New patient visit (30+ min) | 21 | $1,900 | $90 |
| Ultrasound scan of pelvic region through rectum | 17 | $1,510 | $89 |
| Injection of drug or substance under skin or into muscle | 15 | $1,351 | $21 |
| Injection, testosterone cypionate, 1 mg | 16 | $1,076 | None |
| Ultrasonic guidance for needle placement | 16 | $921 | $58 |
| Ultrasound measurement of bladder capacity after voiding | 37 | $769 | $18 |
| Manual urinalysis test with examination using microscope, non-automated | 76 | $351 | $4 |
| Electronic assessment of bladder emptying | 11 | $182 | $15 |
2014: 14 services
| Short return visit (20+ min) | 303 | $28,756 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $14,631 | None |
| Return visit (30+ min) | 85 | $10,620 | $91 |
| Short return visit | 36 | $8,081 | $38 |
| Diagnostic exam of bladder and urethra using an endoscope | 23 | $6,606 | $174 |
| New patient visit (45+ min) | 42 | $6,245 | $149 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,030 | $172 |
| Simple bladder irrigation and/or instillation | 24 | $2,824 | $71 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 19 | $2,561 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,242 | $64 |
| New patient visit (30+ min) | 22 | $2,006 | $91 |
| Injection of drug or substance under skin or into muscle | 17 | $1,096 | $25 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 21 | $986 | None |
| Ultrasound measurement of bladder capacity after voiding | 31 | $662 | $18 |
2013: 17 services
| Short return visit (20+ min) | 336 | $31,249 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 22 | $22,261 | None |
| Short return visit | 69 | $12,104 | $40 |
| New patient visit (30+ min) | 109 | $9,055 | $83 |
| Diagnostic exam of bladder and urethra using an endoscope | 28 | $8,538 | $190 |
| Return visit (30+ min) | 61 | $6,908 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,882 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $4,567 | $63 |
| Ultrasonic guidance for needle placement | 20 | $4,301 | $215 |
| Biopsy of prostate gland | 19 | $3,808 | $200 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $3,221 | $33 |
| Simple bladder irrigation and/or instillation | 22 | $2,620 | $75 |
| Ultrasound scan of pelvic region through rectum | 20 | $1,438 | $72 |
| Insertion of stent in ureter using an endoscope | 12 | $949 | $73 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 19 | $919 | None |
| Ultrasound measurement of bladder capacity after voiding | 32 | $675 | $18 |
| Injection of drug or substance under skin or into muscle | 11 | $183 | $13 |
Money from drug and device companies
$137 in 2022
| 2022 | 2 | 7 | None | $137 |
| 2021 | 3 | 7 | None | $162 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 3 | 6 | None | $103 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Xtandi | $125 | 6 payments
|
| Janssen Biotech | Erleada | $12 | 1 payment
|
See all 7 published payments
| Astellas Pharma US | Education · 2022-11-30 | None | $85 |
| Astellas Pharma US | Meals · 2022-08-03 | Xtandi | $12 |
| Astellas Pharma US | Meals · 2022-08-03 | Xtandi | $1 |
| Astellas Pharma US | Meals · 2022-06-27 | Xtandi | $9 |
| Astellas Pharma US | Meals · 2022-05-31 | Xtandi | $10 |
| Astellas Pharma US | Meals · 2022-03-15 | Xtandi | $8 |
| Janssen Biotech | Meals · 2022-03-02 | Erleada | $12 |
See earlier years (2021, 2020, 2019)
2021: $162
| AbbVie | Lupron Depot | $77 | 3 payments
|
| Pfizer | Eliquis | $45 | 2 payments
|
| Astellas Pharma US | Xtandi | $40 | 2 payments
|
2020: $18
| AbbVie | Lupron Depot | $18 | 1 payment
|
2019: $103
| Pfizer | Eliquis | $69 | 4 payments
|
| Astellas Pharma US | Xtandi | $21 | 1 payment
|
| Allergan | Linzess | $13 | 1 payment
|
Professional record
- NPI
- 1447244785
- Licence
- CA G25099California G25099: Current · expires 2029-02-28
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 16450 Matilija Dr, Los Gatos, CA, 95030
- NPI first listed
- 2005-09-01
- NPI last updated
- 2023-10-24
- NPI record certified
- 2023-10-24
This is when the NPI record was last certified, not a medical board exam.